Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings, 7395-7396 [2019-03752]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 42 / Monday, March 4, 2019 / Notices
Dated: February 26, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–03751 Filed 3–1–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK–17–031:
Characterization and Discovery of Novel
Autoantigens and Epitopes in Type 1
Diabetes (R01).
Date: March 25, 2019.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Dianne Camp, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7013, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–7682,
campd@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Mental Health Services Member Conflict.
Date: March 22, 2019.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Boulevard, Room 6153, MSC
9606, Bethesda, MD 20892, 301–451–2356,
gavinevanskm@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Career Enhancement Awards.
Date: March 29, 2019.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Aileen Schulte, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6140, MSC 9608,
Bethesda, MD 20892–9608, 301–443–1225,
aschulte@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: February 26, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: February 26, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–03805 Filed 3–1–19; 8:45 am]
[FR Doc. 2019–03806 Filed 3–1–19; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:33 Mar 01, 2019
Jkt 247001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
7395
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Member Conflict
SEP.
Date: March 26, 2019.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Christiane M. Robbins,
Scientific Review Officer, Scientific Review
Branch (SRB), DER, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, DHHS, 6710B
Rockledge Drive, Rm. 2121A, Bethesda, MD
20817, 301–451–4989, crobbins@
mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Contraception
Research Centers Program (U54 Clinical Trial
Optional).
Date: April 29–30, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase,
Pavilion 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Joanna Kubler-Kielb,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, DHHS, 6710B Rockledge
Drive, Bethesda, MD 20817, 301–435–6916,
kielbj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
E:\FR\FM\04MRN1.SGM
04MRN1
7396
Federal Register / Vol. 84, No. 42 / Monday, March 4, 2019 / Notices
Dated: February 26, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–03752 Filed 3–1–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Treatment; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Treatment
(CSAT) National Advisory Council
(NAC) will meet on March 28, 2019,
1:00 p.m.–4:30 p.m. (EDT).
The meeting is open and will include
consideration of minutes from the
SAMHSA CSAT NAC meeting of August
1, 2018; the Director’s Report; updates
from the Division Directors, discussions
on recovery housing, and discussions
expanding access to MedicationAssisted Treatment.
The meeting will be held via WebEx
and telephone only. Interested persons
may present data, information, or views,
orally or in writing, on issues pending
before the Council. Written submissions
should be forwarded to the contact
person on or before March 20, 2019.
Oral presentations from the public will
be scheduled at the conclusion of the
meeting. Individuals interested in
making oral presentations must notify
the contact person on or before March
20, 2019. Five minutes will be allotted
for each presentation.
This is an open public meeting that
will be conducted via WebEx and
telephone. Registration is required to
participate during this meeting. To
attend virtually, or to obtain the call-in
number and access code, submit written
or brief oral comments, or request
CBPL No.
27–01
27–03
27–06
27–11
27–13
.....
.....
.....
.....
.....
special accommodations for persons
with disabilities, please register on-line
at https://snacregister.samhsa.gov/
MeetingList.aspx, or communicate with
the CSAT National Advisory Council
Designated Federal Officer; Tracy Goss
(see contact information below).
Meeting information and a roster of
Council members may be obtained by
accessing the SAMHSA Committee
website at https://www.samhsa.gov/
about-us/advisory-councils/csatnational-advisory-council or by
contacting the CSAT National Advisory
Council Designated Federal Officer;
Tracy Goss (see contact information
below).
Council Name: SAMHSA’s Center for
Substance Abuse Treatment National
Advisory Council.
Date/Time/Type: March 28, 2019,
1:00 p.m.–4:30 p.m. EDT, Open.
Place: SAMHSA, 5600 Fishers Lane,
Rockville, Maryland 20857.
Contact: Tracy Goss, Designated
Federal Officer, CSAT National
Advisory Council, 5600 Fishers Lane,
Rockville, Maryland 20857 (mail).
Telephone: (240) 276–0759. Fax: (240)
276–2252. Email: tracy.goss@
samhsa.hhs.gov.
Dated: February 26, 2019.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2019–03743 Filed 3–1–19; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation and Approval of SGS
North America, Inc. (East Alton, IL), as
a Commercial Gauger and Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation and
approval of SGS North America, Inc., as
a commercial gauger and laboratory.
AGENCY:
Notice is hereby given,
pursuant to CBP regulations, that SGS
North America, Inc. (East Alton, IL), has
been approved to gauge and accredited
to test petroleum and petroleum
products for customs purposes for the
next three years as of September 5,
2018.
SUMMARY:
SGS North America, Inc., was
accredited and approved as a
commercial gauger and laboratory as of
September 5, 2018. The next triennial
inspection date will be scheduled for
September 2021.
DATES:
Mr.
Stephen Cassata, Laboratories and
Scientific Services, U.S. Customs and
Border Protection, 1300 Pennsylvania
Avenue NW, Suite 1500N, Washington,
DC 20229, tel. 202–344–1060.
FOR FURTHER INFORMATION CONTACT:
Notice is
hereby given pursuant to 19 CFR 151.12
and 19 CFR 151.13, that SGS North
America, Inc., 300 George St., East
Alton, IL 62024, has been approved to
gauge and accredited to test petroleum
and petroleum products for customs
purposes, in accordance with the
provisions of 19 CFR 151.12 and 19 CFR
151.13. SGS North America, Inc., is
approved for the following gauging
procedures for petroleum and certain
petroleum products set forth by the
American Petroleum Institute (API):
SUPPLEMENTARY INFORMATION:
API Chapters
Title
3 .....................
7 .....................
8 .....................
12 ...................
17 ...................
Tank gauging.
Temperature Determination.
Sampling.
Calculations.
Maritime Measurements.
SGS North America, Inc., is
accredited for the following laboratory
analysis procedures and methods for
petroleum and certain petroleum
products set forth by the U.S. Customs
and Border Protection Laboratory
Methods (CBPL) and American Society
for Testing and Materials (ASTM):
ASTM
Title
D287
D4006
D473
D445
D4294
Standard Test Method for API Gravity of Crude Petroleum and Petroleum Products (Hydrometer Method).
Standard Test Method for Water in Crude Oil by Distillation.
Standard Test Method for Sediment in Crude Oils and Fuel Oils by the Extraction Method
Standard Test Method for Kinematic Viscosity of Transparent and Opaque Liquids.
Standard Test Method for Sulfur in Petroleum and Petroleum Products by Energy-Dispersive X-ray Fluorescence Spectrometry.
Anyone wishing to employ this entity
to conduct laboratory analyses and
gauger services should request and
receive written assurances from the
entity that it is accredited or approved
VerDate Sep<11>2014
17:33 Mar 01, 2019
Jkt 247001
by the U.S. Customs and Border
Protection to conduct the specific test or
gauger service requested. Alternatively,
inquiries regarding the specific test or
gauger service this entity is accredited
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
or approved to perform may be directed
to the U.S. Customs and Border
Protection by calling (202) 344–1060.
The inquiry may also be sent to
cbp.labhq@dhs.gov. Please reference the
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 84, Number 42 (Monday, March 4, 2019)]
[Notices]
[Pages 7395-7396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03752]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Member Conflict SEP.
Date: March 26, 2019.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6710B Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Christiane M. Robbins, Scientific Review
Officer, Scientific Review Branch (SRB), DER, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, DHHS,
6710B Rockledge Drive, Rm. 2121A, Bethesda, MD 20817, 301-451-4989,
crobbins@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Contraception Research Centers
Program (U54 Clinical Trial Optional).
Date: April 29-30, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase, Pavilion 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Joanna Kubler-Kielb, Scientific Review Officer,
Scientific Review Branch, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, NIH, DHHS, 6710B Rockledge
Drive, Bethesda, MD 20817, 301-435-6916, kielbj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
[[Page 7396]]
Dated: February 26, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-03752 Filed 3-1-19; 8:45 am]
BILLING CODE 4140-01-P
